14 Einträge gefunden

1. Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age

   1. Burkhardt, Birgit
   2. Michgehl, Ulf
   3. Rohde, Jonas
   4. Erdmann, Tabea
   5. Berning, Philipp
   6. Reutter, Katrin
   7. Rohde, Marius

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Clofarabine increases the eradication of minimal residual disease of primary B-precursor acute lymphoblastic leukemia compared to high-dose cytarabine without improvement of outcome. Results from the randomized clinical trial 08-09 of the Cooperative Acute Lymphoblastic Leukemia Study Group

   1. Escherich, Gabriele
   2. Zur Stadt, Udo
   3. Borkhardt, Arndt
   4. Dilloo, Dagmar
   5. Faber, Jörg
   6. Feuchtinger, Tobias
   7. Imschweiler, Thomas

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. Thirteen-month-old girl with hyporegenerative macrocytic anemia due to Brown-Vialetto-Van Laere syndrome 2

   1. Naami, Nibras
   2. Borkhardt, Arndt
   3. Yoshimi, Ayami
   4. Grinstein, Lev
   5. Escherich, Gabriele

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
4. Amsacrine combined with etoposide and methylprednisolone is a feasible and safe component in first-line intensified treatment of pediatric patients with high-risk acute lymphoblastic leukemia in CoALL08-09 trial

   1. Mezger, Kerstin
   2. Ebert, Sabine
   3. Muhle, Hannah Elisa
   4. Stadt, Udo Zur
   5. Borkhardt, Arndt
   6. Dilloo, Dagmar
   7. Faber, Jörg

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
5. Improving Stratification for Children With Late Bone Marrow B-Cell Acute Lymphoblastic Leukemia Relapses With Refined Response Classification and Integration of Genetics

   1. Eckert, Cornelia
   2. Groeneveld-Krentz, Stefanie
   3. Kirschner-Schwabe, Renate
   4. Hagedorn, Nikola
   5. Chen-Santel, Christiane
   6. Bader, Peter
   7. Borkhardt, Arndt

   2019 - Forschungsinformationssystem des UKE
6. Daunorubicin during delayed intensification decreases the incidence of infectious complications - a randomized comparison in trial CoALL 08-09

   1. Schramm, Franziska
   2. Zimmermann, Martin
   3. Jorch, Norbert
   4. Pekrun, Arnulf
   5. Borkhardt, Arndt
   6. Imschweiler, Thomas
   7. Christiansen, Holger

   2019 - Forschungsinformationssystem des UKE
7. Results of CoALL 07-03 study childhood ALL based on combined risk assessment by in vivo and in vitro pharmacosensitivity

   1. Schramm, Franziska
   2. Zur Stadt, Udo
   3. Zimmermann, Martin
   4. Jorch, Norbert
   5. Pekrun, Arnulf
   6. Borkhardt, Arndt
   7. Imschweiler, Thomas

   2019 - Forschungsinformationssystem des UKE
8. Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology

   1. Ripperger, Tim
   2. Bielack, Stefan S
   3. Borkhardt, Arndt
   4. Brecht, Ines B
   5. Burkhardt, Birgit
   6. Calaminus, Gabriele
   7. Debatin, Klaus-Michael

   2017 - Forschungsinformationssystem des UKE
9. Homozygous HOXB1 loss-of-function mutation in a large family with hereditary congenital facial paresis

   1. Vogel, Markus
   2. Velleuer, Eunike
   3. Schmidt-Jiménez, Leon F
   4. Mayatepek, Ertan
   5. Borkhardt, Arndt
   6. Alawi, Malik
   7. Kutsche, Kerstin

   2016 - Forschungsinformationssystem des UKE
10. Use of allogeneic hematopoietic stem-cell transplantation based on minimal residual disease response improves outcomes for children with relapsed acute lymphoblastic leukemia in the intermediate-risk group

    1. Eckert, Cornelia
    2. Henze, Günter
    3. Seeger, Karlheinz
    4. Hagedorn, Nikola
    5. Mann, Georg
    6. Panzer-Grümayer, Renate
    7. Peters, Christina

    2013 - Forschungsinformationssystem des UKE
11. Minimal residual disease after induction is the strongest predictor of prognosis in intermediate risk relapsed acute lymphoblastic leukaemia - long-term results of trial ALL-REZ BFM P95/96.

    1. Eckert, Cornelia
    2. von Stackelberg, Arend
    3. Seeger, Karl
    4. Groeneveld, Tom W L
    5. Peters, Christina
    6. Klingebiel, Thomas
    7. Borkhardt, Arndt

    2013 - Forschungsinformationssystem des UKE
12. Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkin's lymphoma and Burkitt leukemia.

    1. Meinhardt, Andrea
    2. Burkhardt, Birgit
    3. Zimmermann, Martin
    4. Borkhardt, Arndt
    5. Kontny, Udo
    6. Klingebiel, Thomas
    7. Berthold, Frank

    2010 - Forschungsinformationssystem des UKE
13. Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group.

    1. Bader, Peter
    2. Kreyenberg, Hermann
    3. Henze, Günter H R
    4. Eckert, Cornelia
    5. Reising, Miriam
    6. Willasch, Andre
    7. Barth, Andrea

    2009 - Forschungsinformationssystem des UKE
14. Immunosuppressive therapy for aplastic anemia in children: a more severe disease predicts better survival.

    1. Führer, Monika
    2. Rampf, Udo
    3. Baumann, Irith
    4. Faldum, Andreas
    5. Niemeyer, Charlotte
    6. Janka-Schaub, Gritta
    7. Friedrich, Wilhelm

    2005 - Forschungsinformationssystem des UKE